| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $227K | — | -50.8% |
| Cost of Revenue | $29.6M | — | +42.3% |
| R&D Expense | $6.7M | — | -79.8% |
| SG&A Expense | $25.6M | — | -16.4% |
| Operating Income | -$65.6M | — | +25.8% |
| Pre-tax Income | -$64.7M | — | +23.4% |
| Income Tax | $30K | — | -37.5% |
| Net Income | -$64.7M | — | +23.4% |
| EPS (Basic) | -$0.81 | — | +66.0% |
| EPS (Diluted) | -$0.81 | — | +66.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $124.8M | -13.7% | -11.3% |
| Short-term Investments | $95.1M | -41.4% | -72.7% |
| Current Assets | $283.5M | -24.0% | -48.2% |
| Total Assets | $750.2M | -6.6% | -17.0% |
| Current Liabilities | $282.6M | +35.0% | +96.5% |
| Long-term Debt | $319.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.5M | — | +29.5% |
| Capital Expenditures | $39.8M | — | -13.6% |
| Investing Cash Flow | $27.8M | — | +271.6% |
| Financing Cash Flow | $5.5M | — | -81.6% |
| Free Cash Flow | -$93.3M | — | +23.5% |
| — |
| Total Liabilities | $526.5M | -0.5% | -16.7% |
| Stockholders' Equity | $223.7M | -18.3% | -17.8% |